title: New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?
authors.forename: Peter
authors.initials: P
authors.lastname: Birner
authors.forename: Rupert
authors.initials: R
authors.lastname: Bartsch
authors.forename: Martin
authors.initials: M
authors.lastname: Schreiber
authors.forename: Peter
authors.initials: P
authors.lastname: Dubsky
authors.forename: Lukas
authors.initials: L
authors.lastname: Kenner
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D051096:Proto-Oncogene Proteins c-ret / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human